A wide range of inflammatory and vascular diseases, including PAN, have been connected to loss-of-function mutations in CECR1 (also known as ADA2), the gene encoding adenosine deaminase 2 (ADA2) [31,32,33,34]. This evidence concerns the gene ADA2 and polyarteritis nodosa.